This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Early autism screening has limited effect Screening for autism at three years of age only identifies those ... (18 Jun 2019)
Research explores the impact of masculine ... Pressures and expectations of masculinity and a lack of ... (18 Jun 2019)
Schizophrenia: adolescence is the ... Schizophrenia causes hallucinations and memory or cognition ... (18 Jun 2019)
Atrial fibrillation linked to increased risk ... Atrial fibrillation (AF) is linked to an increased risk of ... (18 Jun 2019)
Study challenges “no pain no gain” ... Patients with peripheral arterial disease should be given the ... (18 Jun 2019)

World Preeclampsia Day - May 22, 2017

Rate this item
(0 votes)

NICE recommends Roche Diagnostic’s blood test to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy. This blood test is more specifically known as the Elecsys immunoassay sFIt-1/PIGF ratio (Roche Diagnostics).

The sFlt-1/PIGF ratio

 

  • The Elecsys® sFlt-1 and Elecsys® PlGF immunoassays are a reliable automated laboratory test to be used as an aid in the diagnosis of Preeclampsia
  • A simple blood test can now deliver clear, reliable results to help identifying patients at risk for potentially life threatening complications
  • The ELecsys sFlt-1 and PlGF biomarkers have the potential to offer major advances and the diagnosis and management of Preeclampsia

Click here for the video link

Read 3542 times Last modified on Tuesday, 23 May 2017 20:22

Media

Click to view the video
More in this category: Erbitux »

Vivian

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…